News Sentiment

BVS sentiment intelligence

Bioventus Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 66 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 11.88 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings

75/100 classification confidence.

Company focus 55

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend active

+13.4% over one week, +39.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Bioventus (NASDAQ:BVS) Reaches New 12-Month High - Here's Why

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Earnings 75/100 classification
One-week reaction 13.4% Price confirming higher
Trend fit Trend active 39.6% over four weeks
Fair value 60.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 51
Negative 2

Relevance

Why the article matched

Direct first
Direct company coverage 55
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
TradingView 29
Market source 18
MarketBeat 3
simplywall.st 3
StockStory 2
Seeking Alpha 1
Zacks 1
dars.gov.et 1

Event Lens

What the news is about

Classified themes
Earnings 31
Market update 23
Balance sheet 6
Analyst action 4
Deals and strategy 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 66
TradingView Direct company coverage

Bioventus, Inc. Class A Actuals & Estimates (LSX:A2APNA)

This article provides an overview of Bioventus, Inc. Class A (A2APNA) stock, including its current price, historical performance, and analyst forecasts. It also details financial actuals and estimates for income, balance sheet, and cash flow, along with information on earnings, r

Tone
Positive 71/100
Event
Earnings
Published
10 Jul 2026 03:40
Source
TradingView
TradingView Direct company coverage

A2APNA Forecast — Price Target — Prediction for 2027

This article provides an in-depth forecast for Bioventus, Inc. Class A (A2APNA) stock, including analyst price targets, past performance, and future earning estimates. It details current stock price, market capitalization, revenue, net income, and confirms that the company does n

Tone
Positive 72/100
Event
Analyst action
Published
08 Jul 2026 12:40
Source
TradingView
TradingView Direct company coverage

A2APNA Stock Price and Chart — LSX:A2APNA

This article provides an overview of Bioventus, Inc. Class A (A2APNA) stock listed on the Lang & Schwarz Exchange, including key financial stats, upcoming earnings, and analyst insights. It details the company's business segments focusing on orthobiologics and musculoskeletal tre

Tone
Neutral 50/100
Event
Earnings
Published
07 Jul 2026 18:13
Source
TradingView
TradingView Direct company coverage

Debt to assets ratio of Bioventus, Inc. Class A – LS:A2APNA

The article provides financial information for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It specifically highlights the debt to assets ratio for the company. The content also mentions the data sources and copyright information.

Tone
Neutral 50/100
Event
Balance sheet
Published
07 Jul 2026 00:13
Source
TradingView
TradingView Direct company coverage

Cash flow from financing activities of Bioventus, Inc. Class A – LS:A2APNA

This article provides financial data specifically on the cash flow from financing activities of Bioventus, Inc. Class A, traded under the symbol LS:A2APNA. The content is presented within the TradingView platform, noting the market status as closed with no trades. It highlights t

Tone
Neutral 50/100
Event
Balance sheet
Published
07 Jul 2026 00:13
Source
TradingView
TradingView Direct company coverage

Cash per share of Bioventus, Inc. Class A – LS:A2APNA

This article provides financial information for Bioventus, Inc. Class A (LS:A2APNA), specifically focusing on its cash per share. It appears to be a financial data page from TradingView, including general market information and links to various financial tools and community featu

Tone
Neutral 50/100
Event
Balance sheet
Published
06 Jul 2026 13:39
Source
TradingView
TradingView Direct company coverage

Return on equity % of Bioventus, Inc. Class A – LS:A2APNA

The article provides a financial overview of Bioventus, Inc. Class A (A2APNA) on TradingView, specifically focusing on its Return on Equity (ROE) percentage. It indicates that the market was closed at the time of access and no trades were recorded. The content is part of a larger

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 13:09
Source
TradingView
TradingView Direct company coverage

Total revenue of Bioventus, Inc. Class A – LS:A2APNA

This article provides financial information for Bioventus, Inc. Class A under the ticker LS:A2APNA on TradingView. It specifically highlights the "Total revenue" section within the financial data for the company. The content appears to be a stub or a section of a larger financial

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 12:40
Source
TradingView
TradingView Direct company coverage

EBITDA of Bioventus, Inc. Class A – LS:A2APNA

This article displays the EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It provides financial data for the company, indicating the period, value, and percentage change. The article focuses solely o

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 12:10
Source
TradingView
TradingView Direct company coverage

Bioventus, Inc. Class A Statistics – LS:A2APNA

This page provides financial statistics and ratios for Bioventus, Inc. Class A (LS:A2APNA) on the Lang & Schwarz Tradecenter, including valuation, profitability, liquidity, solvency ratios, and per-share metrics. Users can access annual or quarterly data going back to 2013, thoug

Tone
Neutral 50/100
Event
Balance sheet
Published
06 Jul 2026 12:10
Source
TradingView
TradingView Direct company coverage

Cash flow from investing activities of Bioventus, Inc. Class A – LS:A2APNA

This article displays the cash flow from investing activities for Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It appears to be a financial data page rather than a traditional article, providing access to financial information without detailed textual analysis. The content

Tone
Neutral 50/100
Event
Balance sheet
Published
06 Jul 2026 12:10
Source
TradingView
TradingView Direct company coverage

Bioventus, Inc. Class A Income Statement – LS:A2APNA

This article presents the income statement for Bioventus, Inc. Class A (A2APNA), indicating the total revenue for the last quarter was 114.33 million EUR, a 14.96% decrease from the previous quarter. The net income for Q1 2026 was 2.69 million EUR. The report includes an overview

Tone
Negative 41/100
Event
Earnings
Published
06 Jul 2026 10:40
Source
TradingView
TradingView Direct company coverage

Equity in earnings of Bioventus, Inc. Class A – LS:A2APNA

This article provides details on the equity in earnings for Bioventus, Inc. Class A (LS:A2APNA), as listed on the Lang & Schwarz Tradecenter. It indicates that the market is currently closed with no trades recorded. The page includes general market and financial data overview, wi

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 03:40
Source
TradingView
TradingView Direct company coverage

Price to sales forward of Bioventus, Inc. Class A – LS:A2APNA

The article focuses on the "Price to sales forward" metric for Bioventus, Inc. Class A, traded under the symbol A2APNA on the Lang & Schwarz Tradecenter. It provides an overview of the financial data available for this company through TradingView, noting that the market was close

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 01:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of Bioventus, Inc. Class A – LS:A2APNA

This page from TradingView provides financial information for Bioventus, Inc. Class A (LS:A2APNA), specifically focusing on its forward price-to-earnings ratio. The content indicates that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. It i

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 00:41
Source
TradingView
TradingView Direct company coverage

Bioventus, Inc. Class A Earnings and Revenue – LS:A2APNA

Bioventus, Inc. Class A (A2APNA) reported strong financial results for the last quarter, with EPS of 0.13 EUR, significantly exceeding the 0.06 EUR estimate. The company also surpassed revenue expectations, bringing in ‪114.33 M‬ EUR against an estimated ‪112.44 M‬ EUR. Analysts

Tone
Positive 70/100
Event
Earnings
Published
06 Jul 2026 00:40
Source
TradingView
TradingView Direct company coverage

Bioventus, Inc. Class A Dividends – LS:A2APNA

The article provides a financial overview of Bioventus, Inc. Class A (LS:A2APNA) on TradingView. It indicates that the market is currently closed with no trades, and offers information on the company's financials, including dividends, earnings, and revenue.

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 00:40
Source
TradingView
TradingView Direct company coverage

EBITDA margin % of Bioventus, Inc. Class A – LS:A2APNA

This article focuses on the EBITDA margin percentage of Bioventus, Inc. Class A, identified by the ticker LS:A2APNA on TradingView. It provides financial data for the company under the "Markets" section, specifically for German stocks in Health Technology and Medical Specialties.

Tone
Neutral 50/100
Event
Earnings
Published
06 Jul 2026 00:40
Source
TradingView
TradingView Direct company coverage

CapEx per share of Bioventus, Inc. Class A – LS:A2APNA

The article focuses on the "CapEx per share" metric for Bioventus, Inc. Class A (LS:A2APNA). It appears to be a financial data page from TradingView, providing an overview of the company's capital expenditure per share. The content includes navigation elements common to a financi

Tone
Neutral 50/100
Event
Market update
Published
06 Jul 2026 00:40
Source
TradingView